Abnormal changes of brain function and structure in patients with T2DM-related cognitive impairment: a neuroimaging meta-analysis and an independent validation

Abnormal changes of brain function and structure in patients with T2DM-related cognitive impairment: a neuroimaging meta-analysis and an independent validation

Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease, and its incidence rate is increasing year by year. Cognitive impairment (mainly manifested as decreased memory, attention, executive function, or information processing speed) is considered a common complication of T2DM1, which seriously affects the quality of life of patients. Compared to healthy people, patients with T2DM had a 150% increased risk of cognitive impairment2. Therefore, it was necessary to evaluate T2DM-related cognitive impairment (T2DM-CI) and provided theoretical basis for effective intervention to delay disease progression. Neuroimaging is one of the most important techniques for exploring the brain changes of T2DM-CI. Functional and structural indicators in neuroimaging research, reflect abnormal changes in brain activity and the gray matter level of the brain caused by T2DM. Therefore, we needed to determine brain regions of patients with T2DM-CI where functional and structural indicators changed together or could not synchronize.

Functional magnetic resonance imaging is a non-invasive imaging technique for measuring blood oxygen level dependent neuronal activity, widely used in the fields of neuroscience and cognitive science3. Various functional indicators such as amplitude of low-frequency fluctuation (ALFF), regional homogeneity (ReHo), and degree centrality (DC) were used to explore the spontaneous changes in brain activity in T2DM-CI patients. ALFF is obtained by calculating the maximum fluctuation of the low-frequency hemodynamic response function (HRF) for each voxel, which is related to the intensity of local neural activity and can directly characterize the spontaneous brain activity of each voxel4. The greater the fluctuation, the more likely it is to be the result of the stronger neural activity. ReHo uses Kendall’s harmony coefficient to measure the time series consistency between the target voxel and its neighboring voxels5. It can reflect the local characteristics of spontaneous brain functional activity, and any abnormal decrease or increase in its value reflects the synchronization or coordination of local brain functional activity, which may be the main underlying cause of cognitive dysfunction in patients6. DC is usually obtained by extracting the time series of one voxel and associating it with the time series of all other voxels in the brain, and then calculating the sum of the correlation coefficients obtained. The higher DC typically indicates more correlation between the voxel and all other voxels, suggesting that neurons within the voxel are more active4.

And previous studies showed that patients with T2DM-CI had significantly decreased ALFF and ReHo values in the occipital lobe and postcentral gyrus7. Besides, it was reported that patients with T2DM-CI had significantly decreased ALFF values in the bilateral middle temporal gyrus, left fusiform gyrus, left middle occipital gyrus, right inferior occipital gyrus; and increased ALFF values in both the bilateral cerebellum posterior lobe and right cerebellum culmen8. In addition, another study found that patients with T2DM-CI had increased DC values in the left superior temporal gyrus, left Heschl gyrus, and left hippocampus9. These studies suggested that T2DM-CI had aberrant spontaneous brain activity.

White matter and gray matter are both indicators of brain structure10,11, and in this meta-analysis, we explored gray matter (GM) which is more associated with neuronal activities. It was reported that patients with T2DM-CI exhibited GM reductions in the left orbital superior, middle, and inferior frontal gyri as well as the right superior frontal gyrus9. In addition, another study found that patients with T2DM-CI had cortical/subcortical GM atrophy in thalamus, putamen, and hippocampus compared to healthy controls (HCs)12. Furthermore, compared to HCs, the patients with T2DM-CI showed reduced GM in the limbic system (i.e., the hippocampus, parahippocampal gyrus, amygdala and uncus)13. In short, studies above demonstrated that the GM abnormalities played a crucial role in the process of T2DM-CI.

Whether the indicators of functional or structural imaging, the results of individual studies were partially consistent and partially inconsistent. Therefore, we conducted a meta-analysis by combining functional and structural indicators to see if the brain regions were overlap with each other. Although previous meta-analyses have explored functional and structural changes in T2DM14, there was still a lack of significant and consistent results in T2DM-CI. Therefore, it was necessary to conduct a meta-analysis of brain functional and structural changes in T2DM-CI patients. In this study, we aimed to collect studies on changes of ALFF, ReHo, DC or GM between T2DM-CI and HCs, and explored brain regions of characteristic change that could provide targets for early detection and intervention of disease. Finally, we conducted validation using our own dataset to validate the results of the meta-analysis.

Materials and methods

Meta-analysis

Protocol and guidance

This neuroimaging meta-analysis followed the standards of PRISMA15(See Supplementary Table 1). The protocol was registered on PROSPERO(CRD42023448917) (https://www.crd.york.ac.uk/prospero/). All works were completed independently by two reviewers (PD and YY), any controversial questions were discussed and resolved with the third reviewer (LFY).

Systemic search and study strategy

The systemic study was searched in databases including PubMed, Web of Science, MEDLINE (void), Cochrane Library from 1 January 2007 to 26 May 2023, which used the keywords as follows: (“Diabetes Mellitus, Type 2” OR “Type 2 Diabetes” OR “NIDDM” OR “T2DM” “Diabetes Mellitus, Type II”) AND (“Cognitive Dysfunction” OR “Cognitive Impairment” OR “Cognitive Decline” OR “Cognitive Disorder” OR “cognitive dissonance” OR “Mild Cognitive Impairment” OR “MCI”) AND (“functional neuroimaging” OR “functional magnetic resonance imaging” OR “fMRI” OR “Functional Brain Imaging” OR “resting state” OR “amplitude of low frequency fluctuation” OR “ALFF” OR “fractional amplitude of low frequency fluctuation” OR “fALFF” OR “regional homogeneity” OR “ReHo” OR “DC” OR “degree centrality”); (“Diabetes Mellitus, Type 2” OR “Type 2 Diabetes” OR “NIDDM” OR “T2DM” “Diabetes Mellitus, Type II”) AND (“Cognitive Dysfunction” OR “Cognitive Impairment” OR “Cognitive Decline” OR “Cognitive Disorder” OR “cognitive dissonance” OR “Mild Cognitive Impairment” OR “MCI”) AND (“cerebral cortex” OR “gray matter” OR “VBM” OR “voxel-based morphometry” OR “thickness” OR “cortical thickness” OR “thinning” OR “cortical thinning”)14,16,17. The detailed search strategies were shown in Supplementary Table 2.

Inclusion criteria (1) original research; (2) study between T2DM-CI and HCs; (3) observational studies using a voxel-based analysis to calculate ALFF, ReHo, DC, or GM changes in the whole brain; (4) research included both male and female adults; (5) the peak coordinates were clearly reported in stereotactic three-dimensional coordinates (Talairach, TAL or Montreal Neurological Institute, MNI); (6) t-values, z-values, or p-values could be extracted; (7) studies using the t-test of two independent samples; (8) cognitive assessments were performed in all subjects, and T2DM had lower cognitive scores than HCs.

Exclusion criteria: (1) not original studies; (2) lack of HCs; (3) research on other functional indicators or white matter, as well as task states fMRI; (4) single gender; (5) not adult; (6) T2DM with severe complications; (7) regions-of-interest (ROI) studies; (8) animal studies; (9) no coordinates and the study quality score (QS) < 17; (10) intervention study; (11) data duplication; (12) lack of cognitive assessment.

Quality assessment, data extraction, and conversion

The quality of total 19 studies (12 functional indicator studies and 7 GM indicator studies) included was assessed by 20-point checklists, and those with a total score below 17 points was excluded18. A detailed list of quality assessments could be found in Supplementary Table 3.

General information (researchers, sex (male/female), cognitive scales, age, education years, duration of T2DM, HbA1c, BMI, Field strength, and coordinate space) for all studies were showed in Table 1. The detailed cognitive scores were showed in Supplementary Table 4. The peak coordinates and t-values of ALFF, ReHo, DC or GM abnormality between T2DM-CI and HCs were extracted for meta-analysis. If there was no t-value in the article, we would use the SDM website (https://www.sdmproject.com/) to convert the p-value or z-value into t-value.

Table 1 General information of function datasets and GM datasets.
Full size table

Voxel-based meta-analysis by AES-SDM

First, we extracted coordinate information and effect values (t-value) from each dataset and prepared the text files according to the correct naming method. Next, we created the SDM table. Finally, we strictly followed the standard steps of the anisotropic effect size-signed differential mapping (AES-SDM) 5.15 software (http://www.sdmproject.com/) for meta-analysis, which could be briefly described as follows:(1) global analysis; (2) preprocessing; (3) mean analysis; (4) threshold analysis; (5) create mask and extract mask. The meta-analyses of ALFF, ReHo, DC and GM were respectively performed in the “Functional MRI or PET” and “VBM-gray matter” templates of AES-SDM software17. The parameters used in this study were anisotropy = 1, isotropic full width at half maximum (FWHM) = 20 mm, probability = 0.0005, peak height threshold = 1, extent threshold = 10 voxels and 100-randomization test17,19. All significant results were visualized by MRIcroGL software between T2DM-CI and HCs20.

Heterogeneity and publication bias assessment

After analyzing the main results using AES-SDM, we extracted the coordinates of the main results using Seed-based d-Mapping-Permutation of Subject Images (PSI-SDM version 6.21), and then calculated the mean and standard deviation respectively17. Next, we would use Stata/SE 16.0 software to analyze heterogeneity17. Finally, the publication bias was evaluated using the default Egger test of SDM and visualized using a funnel plot16,17,21.

Jackknife sensitivity analysis

To evaluate the reliability and stability of the main results, we conducted a jackknife sensitivity analysis by AES-SDM22. After preprocessing, we conducted sensitivity analysis in the main analysis by excluding one study at a time18. If the main outcome existed in all or most studies, it could be considered stable and significant18.

Meta-regression analysis

To explore the impact of potential risk factors including age, percentage of female patients, BMI, education, T2DM duration, HbA1c, and MMSE/MoCA score on function/GM abnormalities in T2DM-CI, a meta-regression in linear model of AES-SDM was performed14. Statistical significance was determined to use a stringent threshold of FWHM = 20 mm, p < 0.0005, cluster-corrected, peak height Z > 1, and cluster >10 voxels in meta-regression analysis14. Meta-regression analysis could exclude findings beyond the brain regions detected in the main analysis.

Validation study

To verify the results of meta-analysis, the brain regions with significant differences obtained from meta-analysis were saved as masks and then validated in our independent data23.

Participants

Prospective collection of 43 T2DM patients with MCI diagnosed at Tangdu Hospital of Air Force Military Medical University from September 2016 to December 2023, including 27 males and 16 females, aged 35–67 years, with an average age of (54.23 ± 9.31) years. During the same period, 42 healthy volunteers matched in gender, age, BMI, and education level were included as a healthy control (HC) group, including 24 males and 18 females, aged 45–69 years, with an average age of (52.21 ± 5.35) years (Supplementary Table 5). Inclusion criteria of T2DM-CI group: According to the 2013 version of Guidelines for the Prevention and Treatment of Type 2 diabetes in China as diagnostic criteria for diagnosing T2DM; Age 18–70 years old; Right-handed; 2324. Inclusion criteria for HC group: Does not comply with the 2013 version of Guidelines for the Prevention and Treatment of Type 2 diabetes in China for diagnosing T2DM; Age 18–70 years old; Right-handed; MMSE score≥27 and MoCA score≥26 points. This study was approved by the Hospital Medical Ethics Committee (NCT02420470), and all study subjects signed a written informed consent form.

Statistical analysis

We saved the brain regions with differences in meta-analysis as masks, and then used the two-sample t-test to analyze whether there were differences in functional indicators (ALFF, ReHo, and DC) and structural indicator (VBM) of T2DM-CI and HCs on the mask. P < 0.05 was considered statistically significant.

Results

Meta-analysis

Systemic search information and general characteristics of included studies

Firstly, we searched from four databases by using theme words and keywords, and ultimately identified 685 articles in GM and 462 articles in function. Secondly, the 235 results of GM datasets and 224 results of function datasets were further removed because of duplication. Finally, 408 articles of GM datasets and 207 articles of function datasets were excluded by reading the title and abstract. In the end, total 19 studies (20 datasets) meeting the inclusion criteria were included in this study, which consisted of 7 GM datasets including 6 gray matter volume (GMV)9,13,25,26,27,28 and 1 cerebral cortical thickness12 and 13 function datasets including 5 ALFF7,8,29,30,31, 4 ReHo7,32,33,34 and 4 DC9,35,36,37. The detailed search flow diagram was showed in Fig. 1.

Fig. 1: Search flow diagram followed the PRISMA statement.
Abnormal changes of brain function and structure in patients with T2DM-related cognitive impairment: a neuroimaging meta-analysis and an independent validation

The systemic searches were separately performed on function (a) and GM studies (b).

Full size image

Detailed general information of function and GM datasets are shown in Table 1. By merging clinical data, on one hand, we found statistical differences in gender (x2 = 5.655, P = 0.017), age (standardized mean difference [SDM] = 0.21, 95% confidence interval [CI] = [0.07, 0.36], Z = 2.83, P = 0.005) and BMI (SDM = 0.21, CI = [0.04, 0.38], Z = 2.37, P = 0.02) between the T2DM-CI and HCs groups in the functional group, there was no difference in the education level (SDM = −0.07, CI = [−0.22, 0.09], Z = 0.88, P = 0.38). On the other hand, we found significant difference in BMI (SDM = 1.16, CI = [0.53, 1.79], Z = 3.61, P = 0.0003) between the T2DM-CI and HCs groups in the GM group, there were no difference in the gender (x2 = 3.072, P = 0.08), age (SDM = 0.12, CI = [−0.52, 0.76], Z = 0.37, P = 0.71) and education level (SDM = −0.44, CI = [−0.93, 0.05], Z = 1.75, P = 0.08).

Brain activity abnormality between T2DM-CI and HCs

According to the main analysis, patients with T2DM-CI showed the brain activity of the left anterior cingulate / paracingulate gyri (ACC. L) (BA24, MNI: −2, 30, 26; SDM-Z = 2.673, P < 0.0000) increased significantly, while the brain activity of the left lingual gyrus (LING. L) (BA18, MNI: −10, −68, −4; SDM-Z = −2.066, P < 0.0005) decreased significantly compared to HCs (Table 2, Fig. 2). AES-SDM software used Q test to assess heterogeneity in main results, but the results are inconsistent. Thus, we used Stata software to evaluate its heterogeneity. The results showed significant heterogeneity (SDM = 0.22, 95% CI = [0.11, 0.34], I2 = 99.7%) in ACC.L and LING.L (SDM = −0.25, 95% CI = [−0.32, −0.18], I2 = 99.2%). The forest plot was given in Supplementary Fig. 1. Jackknife analysis showed 13 of 13 times in ACC. L and 9 of 13 times in LING. L (Supplementary Table 6). Egger’s test showed no publication bias in ACC.L and LING.L (P > 0.05) (Supplementary Fig. 3).

Table 2 Clusters of brain activity and GM differences in patients with T2DM-CI compared to HCs.
Full size table
Fig. 2: Significant brain activity abnormalities between T2DM-CI and HCs.
figure 2

Patients with T2DM-CI showed significant increased brain activity (Red) in left anterior cingulate/paracingulate gyri (ACC.L, BA 24) (a) compared to HCs (P < 0.0005), while significant decreased brain activity (Blue) in left lingual gyrus (LING.L, BA18) (b).

Full size image

GM abnormality between T2DM-CI and HCs

According to the main analysis, patients with T2DM-CI showed the significant GM reduction in the right superior temporal gyrus (STG. R) (BA42, MNI: 58, −22, 12; SDM-Z = −2.153, P < 0.0001) and left inferior occipital gyrus (IOG. L) (BA19, MNI: −38, −82, −4; SDM-Z = -2.027, P < 0.0005) compared to HCs (Table 2, Fig. 3). AES-SDM software used Q test to assess heterogeneity in main results, but the results are inconsistent. Thus, we used Stata software to evaluate its heterogeneity. The results showed that there was significant heterogeneity (SDM = −0.48, 95% CI = [−0.86, −0.09], I2 = 99.9%) in IOG.L and STG.R (SDM = −0.30, 95% CI = [−0.43, −0.17], I2 = 99.6%). The forest plot was given in Supplementary Fig. 2. Jackknife analysis showed 4 of 7 times in STG. R and 4 of 7 times in IOG. L (Supplementary Table 6). Egger’s test showed no publication bias in STG.R and IOG.L (P > 0.05) (Supplementary Fig. 4).

Fig. 3: Significant GM abnormalities between T2DM-CI and HCs.
figure 3

Patients with T2DM-CI showed significant decreased GM (Blue) in right superior temporal gyrus (STG.R, BA42) (a) and left inferior occipital gyrus (IOG.L, BA 19) (b) compared to HCs (P < 0.0005). No increased GM was found in T2DM-CI compared to HCs (P = 0.0005).

Full size image

Meta-regression analysis

The meta-regression analysis showed that age, BMI, education level, HbA1c, MMSE and MoCA had no significant effect on the main results of function group and GM group, while the brain activity reduction in LING. L was negatively related with the percentage of female patients (Table 3, Fig. 4), the GM reduction in IOG.L was negatively related with T2DM duration (Table 3, Fig. 5).

Table 3 The relationship between Age, BMI, MoCA and decreased brain activity/GM in patients with T2DM-CI.
Full size table
Fig. 4: The relationship between percentage of female patients and decreased brain activity in patients with T2DM-CI.
figure 4

According to the meta-regression, the percentage of female patients was negatively related with the decreased brain activity in LING.L (r = −0.608, P < 0.0005).

Full size image
Fig. 5: The relationship between T2DM duration and decreased GM in patients with T2DM-CI.
figure 5

According to the meta-regression, the T2DM duration was negatively related with the decreased GM in IOG.L (r = −0.775, P < 0.0005).

Full size image

Validation

In the functional indicator group, we found that there was only intergroup difference in LING.L between T2DM-CI and HCs on ReHo, while there were no intergroup differences in ALFF and DC. There were no intergroup differences in ACC.L between T2DM-CI and HCs on ALFF, ReHo, and DC (Supplementary Table 7).

In the structural indicator group, we found that there were no intergroup differences in STG. R and IOG. L between T2DM-CI and HCs on VBM (Supplementary Table 8).

Discussion

The brain activity and GM abnormalities in patients with T2DM-CI were first to be explored in the meta-analysis. The ALFF, ReHo and DC changes between T2DM-CI and HCs were combined to explore the specific brain regions involved in functional alterations of brain activity. The GMV and cortical thickness changes between T2DM-CI and HCs were combined to explore the specific brain regions of GM alterations. Main analysis showed that the brain activity in the left anterior cingulate/paracingulate gyri (BA24) of T2DM-CI patients increased significantly, the brain activity of the left lingual gyrus (BA18) of T2DM-CI patients decreased significantly, and the GM changes in the right superior in temporal gyrus (BA42) and left inferior occipital gyrus (BA19) of T2DM-CI patients decreased significantly. Jackknife sensitivity analysis showed that these peak coordinates are relatively stable and highly repetitive.

According to our main results, the abnormal brain function within specific brain regions of T2DM-CI patients was consistent with previous systematic reviews and meta-analysis studies on brain function changes caused by T2DM. For example, previous meta-analysis reported that the brain activity of T2DM patients significantly decreased in the bilateral lingual gyrus (LING), left postcentral gyrus, right inferior temporal gyrus, right cerebellar culmen, right insula and right posterior cingulate cortex38. In addition, another meta-analysis reported that patients with T2DM showed hypoactivity in the right medial superior frontal gyrus, right superior temporal gyrus, and left lingual gyrus (LING)39. Furthermore, a recent meta-analysis showed that T2DM patients had decreased brain activity in the right insula, bilateral lingual gyrus (LING), left supramarginal gyrus and left calcarine fissure and surrounding cortex14. Similarly, our meta-analysis and validation analysis found that the patients with T2DM-CI had the significant reduced brain activity in LING.L compared to HCs. All in all, the decrease in brain activity of LING.L was robust in both T2DM and T2DM-CI. It was reported that LING is the important component of the visual cortex, responsible for visual memory and vision processing40. Previous animal experiments showed that visual impairment in T2DM rats occurred before cognition41,42. In addition, other studies also found that the patients with T2DM-CI were more likely to suffer from visual impairment such as decreased vision and retinopathy43,44. Therefore, visual impairment may be an early manifestation of T2DM-CI. Furthermore, we also found that patients with T2DM-CI had the significant decreased GM in STG.R compared to HCs, which was consistent with the results of previous meta-analysis studies. For example, previous meta-analysis reported that T2DM patients had significant decreased GM in the STG.R14. Meanwhile, the other meta-analyses showed that T2DM patients had reduced GM in the bilateral STG or STG.L compared to HCs45,46. Recently, our research team conducted a meta-analysis and found that T2DM-CI patients showed a significant and sustained decrease in GM in the STG.L compared to HCs16. Similarly, in this meta-analysis, we also found the patients of T2DM-CI showed a significant reduction of GM in the STG.R. In a word, these meta-analysis studies indicated that the decrease in GM of STG was robust in both T2DM and T2DM-CI. However, our validation analysis showed there was no intergroup difference in GMV between T2DM-CI and HCs in STG. R. This may be because our sample size was small and we only analyzed the GMV, which was different from the GM indicator literature included in previous meta-analysis. It was reported that STG was critical for extracting meaningful linguistic features from speech input47,48. Previous studies also showed that decreased GM in STG was associated with CI in patients with T2DM and multiple sclerosis13,49. Therefore, the decreased GM in STG may be a specific biomarker for T2DM switch into T2DM-CI.

In addition to the robust results in both T2DM and T2DM-CI, we also found that the brain activity of T2DM-CI was significantly enhanced in ACC.L, while decreased GM in IOG.L. The anterior cingulate cortex is an important brain region involved in various functions such as attention, emotion, and cognition50,51. It was reported that the inferior occipital gyrus (IOG) is located in the occipital lobe, which related to the transmission of visual information, responsible for transmitting analysis and processing information to other brain regions52. Therefore, the functions of LING and IOG were consistent. That is to say, the brain function and structure parts of T2DM-CI patients were coupled. However, T2DM-CI patients showed a significant decrease in GM in the STG.R, while no decrease in brain activity was observed in the STG.R. Therefore, we could conclude that functional and structural abnormities within different brain regions synergistically regulate the visual impairment of T2DM-CI.

In addition, these brain regions are unique to patients with T2DM cognitive impairment and are inconsistent with the cognitive impairment caused by caused by other forms, such as obesity and hypertension. Obesity and hypertension are closely related to T2DM. They are important risk factors for T2DM, and T2DM will in turn increase the risk of hypertension. Therefore, we will separately elaborate on the brain regions associated with cognitive impairment caused by obesity and hypertension, further confirming that the brain regions obtained in this meta-analysis are unique to T2DM-related cognitive impairment. For example, study found that specific areas of the brain damaged by hypertension, including the putamen, anterior thalamic radiation, anterior coronal radiation, and anterior limb of the internal capsule, can lead to cognitive decline53. Among them, the putamen is responsible for regulating movement and influencing various types of learning54; anterior thalamic radiation involves executive functions, such as planning simple and complex daily tasks55; anterior coronal radiation and anterior limb of the internal capsule involve decision-making and emotional management53. There was also study indicating that obesity damaged memory related brain regions, leading to a decline in memory56. In addition, increasing evidence emphasizes cognitive impairments related to obesity, including decision-making57, inhibitory control58, learning/memory59, and attention impairment60. Therefore, it further confirmed that visual related brain regions were specific brain regions associated with T2DM related cognitive impairment.

However, this study had high heterogeneity. Studies showed that when analyzing T2DM-CI, we should consider the comprehensive background of the underlying processes and their impact on the results61,62, such as population characteristics, disease characteristics, cognitive assessment tools, and MRI protocols. We should have conducted subgroup analysis to determine whether data processing methods affect changes in brain function and structure, but due to limited literature, we were unable to do so. Therefore, we only conducted a meta-regression analysis on the population characteristics (age, gender, BMI, and education level), disease characteristics (T2DM duration and HbA1c) and common cognitive assessment tools (MoCA, MMSE). It is showed that age, BMI, education level, HbA1c, MMSE and MoCA had no significant effect on the main results of function and GM changes, while percentage of female patients and T2DM duration might play an effect on functional or structural alterations in T2DM-CI. But some rare cognitive assessment tools, disease features (disease control and patient treatment variability), and MRI protocols could not be corrected due to lack of adequate data. Therefore, we speculated that gender, T2DM duration, disease control and patient treatment variability, rare cognitive assessment tools and MRI protocols were the main cause of heterogeneity in our meta-analysis.

Our study also had some limitations as follows: Firstly, we only searched four databases, which may result in incomplete literature retrieval; secondly, the definition of T2DM-CI is relatively broad, but even so, the retrieved datasets are still quite limited; thirdly, we only studied partial indicators in brain activity, which may make the results less universal; fourthly, we conducted a unified analysis of GMV and cortical thickness due to limited literature, which could lead to a certain degree of heterogeneity; fifthly, although we speculated that heterogeneity in the meta-analysis might be due to some rare cognitive assessment tools, disease control, patient treatment variability and MRI protocols, there were insufficient datas to calibrate the results with them as covariates; sixthly, we only validated some of the results in our validation study, which may be due to the small sample size of the strict definition of T2DM-CI. A small sample size in brain imaging research will lead to non reproducible associations. When the sample size reaches several thousand people, the repeatability begins to increase. In the future, we will expand the sample size to further validate the reliability of the results.

In conclusion, the decrease of brain activity in LING.L and the decrease of GM in IOG.L were closely related to visual impairment in T2DM-CI patients. Functional and structural abnormalities within different brain regions synergistically may regulate the visual impairment of T2DM-CI. In the future, we need to closely monitor the visual changes of T2DM patients. Early intervention for visual impairment in T2DM patients can delay its further development into cognitive impairment, improve their quality of life and clinical management ability. It also provides early biomarkers for elucidating the mechanism of cognitive impairment in T2DM.

Related Articles

Energy metabolism in health and diseases

Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This review provides an extensive overview of advancements in energy metabolism research, elucidating critical pathways such as glycolysis, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism, along with their intricate regulatory mechanisms. The homeostatic balance of these processes is crucial; however, in pathological states such as neurodegenerative diseases, autoimmune disorders, and cancer, extensive metabolic reprogramming occurs, resulting in impaired glucose metabolism and mitochondrial dysfunction, which accelerate disease progression. Recent investigations into key regulatory pathways, including mechanistic target of rapamycin, sirtuins, and adenosine monophosphate-activated protein kinase, have considerably deepened our understanding of metabolic dysregulation and opened new avenues for therapeutic innovation. Emerging technologies, such as fluorescent probes, nano-biomaterials, and metabolomic analyses, promise substantial improvements in diagnostic precision. This review critically examines recent advancements and ongoing challenges in metabolism research, emphasizing its potential for precision diagnostics and personalized therapeutic interventions. Future studies should prioritize unraveling the regulatory mechanisms of energy metabolism and the dynamics of intercellular energy interactions. Integrating cutting-edge gene-editing technologies and multi-omics approaches, the development of multi-target pharmaceuticals in synergy with existing therapies such as immunotherapy and dietary interventions could enhance therapeutic efficacy. Personalized metabolic analysis is indispensable for crafting tailored treatment protocols, ultimately providing more accurate medical solutions for patients. This review aims to deepen the understanding and improve the application of energy metabolism to drive innovative diagnostic and therapeutic strategies.

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

Macrophages are immune cells belonging to the mononuclear phagocyte system. They play crucial roles in immune defense, surveillance, and homeostasis. This review systematically discusses the types of hematopoietic progenitors that give rise to macrophages, including primitive hematopoietic progenitors, erythro-myeloid progenitors, and hematopoietic stem cells. These progenitors have distinct genetic backgrounds and developmental processes. Accordingly, macrophages exhibit complex and diverse functions in the body, including phagocytosis and clearance of cellular debris, antigen presentation, and immune response, regulation of inflammation and cytokine production, tissue remodeling and repair, and multi-level regulatory signaling pathways/crosstalk involved in homeostasis and physiology. Besides, tumor-associated macrophages are a key component of the TME, exhibiting both anti-tumor and pro-tumor properties. Furthermore, the functional status of macrophages is closely linked to the development of various diseases, including cancer, autoimmune disorders, cardiovascular disease, neurodegenerative diseases, metabolic conditions, and trauma. Targeting macrophages has emerged as a promising therapeutic strategy in these contexts. Clinical trials of macrophage-based targeted drugs, macrophage-based immunotherapies, and nanoparticle-based therapy were comprehensively summarized. Potential challenges and future directions in targeting macrophages have also been discussed. Overall, our review highlights the significance of this versatile immune cell in human health and disease, which is expected to inform future research and clinical practice.

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines. The integration of novel drug design and synthesis techniques, display library technology, delivery systems, bioengineering advancements, and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs, effectively addressing the obstacles associated with their character, such as the rapid clearance and degradation, necessitating subcutaneous injection leading to increasing patient discomfort, and ultimately advancing translational research efforts. Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions, such as diabetes mellitus, weight loss, oncology, and rare diseases, and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines. This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics, delivery platforms, and vaccines. It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs, as well as the recent advancements in screening, design, and delivery technologies. The accelerated advancement in the development of novel peptide-based therapeutics, including peptide-drug complexes, new peptide-based vaccines, and innovative peptide-based diagnostic reagents, has the potential to promote the era of precise customization of disease therapeutic schedule.

Diabetic foot exacerbates gut mycobiome dysbiosis in adult patients with type 2 diabetes mellitus: revealing diagnostic markers

Type 2 diabetes mellitus (T2DM) is globally recognized as a significant health concern, with diabetic foot (DF) identified as a severe long-term complication that can lead to tissue death or amputation. The discovery of the impact of mycobiota, a diverse group of multicellular eukaryotes in the gut microbiome, on the onset of endocrine disorders holds great significance. Therefore, this research aimed to examine variations in fungal mycobiome and identify potential biomarkers for T2DM and T2DM-DF. Fecal and blood samples were collected from 33 individuals with T2DM, 32 individuals with T2DM-DF, and 32 healthy individuals without any health conditions (HC). Blood samples were used for laboratory parameters analysis, while total DNA was extracted from fecal samples and sequenced using Illumina 18s rRNA. Bioinformatics tools were employed to analyze fungal abundance and diversity, revealing differentially expressed fungal species and signature fungi that distinguished between T2DM, T2DM-DF, and HC groups. Firstly, significant alterations in some laboratory parameters were observed among the three groups, which also differed between T2DM and T2DM-DF. The diversity of gut fungi in T2DM and T2DM-DF significantly differed from that of the HC group; however, more pronounced changes were observed in T2DM-DF. Additionally, two significantly altered phyla, Ascomycota and Basidiomycota, were identified with higher Ascomycota abundance but lower Basidiomycota abundance in both the T2DM and T2DM-DF compared to the HC group. Furthermore, the top 15 fungi showing significant changes at the species level included a notable decrease in Rhodotorula_mucilaginosa abundance in patients with T2DM compared to HC and a substantial increase in unclassified_g_Candida abundance specifically seen only among patients with T2DM-DF, but not among those diagnosed with T2DM or HC. Thirdly, KEGG was employed to analyze enzyme expression across the three groups, revealing a more pronounced alteration in gut fungal function within T2DM-DF compared to T2DM. Subsequently, to accurately identify signature fungi in each group, a random forest was utilized to rank the top 15 significant fungi. Notably, 11 fungi were identified as potential biomarkers for distinguishing T2DM or T2DM-DF from HC, while eight fungi could discriminate between T2DM and T2DM-DF. Furthermore, receiver operating characteristic curve (ROC) analysis demonstrated enhanced accuracy of predicted outcomes. These findings suggest that changes in fungal mycobiome are closely associated with the progression and complications of T2DM and DF, offering promising prospects for diagnosis and treatment.

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status

The pancreas, an organ with dual functions, regulates blood glucose levels through the endocrine system by secreting hormones such as insulin and glucagon. It also aids digestion through the exocrine system by secreting digestive enzymes. Complex interactions and signaling mechanisms between the endocrine and exocrine functions of the pancreas play a crucial role in maintaining metabolic homeostasis and overall health. Compelling evidence indicates direct and indirect crosstalk between the endocrine and exocrine parts, influencing the development of diseases affecting both. From a developmental perspective, the exocrine and endocrine parts share the same origin—the “tip-trunk” domain. In certain circumstances, pancreatic exocrine cells may transdifferentiate into endocrine-like cells, such as insulin-secreting cells. Additionally, several pancreatic diseases, including pancreatic cancer, pancreatitis, and diabetes, exhibit potential relevance to both endocrine and exocrine functions. Endocrine cells may communicate with exocrine cells directly through cytokines or indirectly by regulating the immune microenvironment. This crosstalk affects the onset and progression of these diseases. This review summarizes the history and milestones of findings related to the exocrine and endocrine pancreas, their embryonic development, phenotypic transformations, signaling roles in health and disease, the endocrine-exocrine crosstalk from the perspective of diseases, and potential therapeutic targets. Elucidating the regulatory mechanisms of pancreatic endocrine and exocrine signaling and provide novel insights for the understanding and treatment of diseases.

Responses

Your email address will not be published. Required fields are marked *